key industries

Healthcare & Life Sciences

Value-based transformation advances as pharma races to innovate and payers demand outcomes. Operators who've led care delivery accelerate results Big Consulting can't deliver.

Hospitals & Health Systems

Life Sciences & Research

Medical Devices & Diagnostics

Payers

Pharmaceuticals & Biotechnology

The Healthcare & Life Sciences Reality check

Where Patient Outcomes Meet Business Imperatives

Value-Based Care Shift

Shifting from fee-for-service to value-based contracts demands new risk capabilities. Leaders who've built VBC programs succeed.

Margin Compression

Rising costs collide with declining reimbursements. Operators who've protected healthcare P&Ls unlock sustainable savings.

Digital Transformation Gap

Legacy systems and fragmented data block AI adoption and clinical insights. Leaders who've modernized health enterprises deliver ROI.

What Makes Us Different

Catalant Delivers Better Business Outcomes With Consulting 2.0

Fit to Purpose

Work with consultants who’ve seen (and solved) your business challenge before.

Flexible Approach

Get the consultants you need for the duration you need them.

Fast Deployment

Build your team and get started in a matter of days, not months.

Fair Value

High standards with low overhead: Catalant provides a far better value for the investment.

SUCCESS stories

Private Equity Expertise in Action

consultants

Meet Our Healthcare & Life Sciences Industry Leaders

Mariana R.

Ex-J&J with 20+ years transforming talent, culture, and organizations across medtech and pharmaceutical industries

Jonathan K.

25 years delivering commercial strategy, market research, and access policy for healthcare and lifesciences

Jeris S.

Healthcare growth leader with 17+ years across the value chain serving payors, providers, pharmacos, PE investors

catalant insights

Latest Healthcare & Life Sciences Industry Thinking

let's talk

Ready to engage operators who understand your healthcare challenges?

Matt Cybulsky

Managing Director, Healthcare